Exploration of Asthma & Allergy

From: A rare complication in Schnitzler syndrome: recall urticaria in a patient treated with anakinra—a case report

Table 1. Laboratory findings at the time of diagnosis of Schnitzler syndrome.

Test name	Result	Normal range	Interpretation
White blood cells	17.83 × 10⁹/L	3.6–10.5 × 10⁹/L	Increased
Neutrophils	12.48 × 10⁹/L	1.5–7.7 × 10⁹/L	Increased
C-reactive protein	12 mg/L	< 5 mg/L	Increased
Erythrocyte sedimentation rate	15 mm/h	< 6 mm/h	Increased
Creatinine	0.8 mg/dL	0.50–0.95 mg/dL	Normal
Aspartate aminotransferase	32 U/L	11–34 U/L	Normal
Alanine aminotransferase	23 U/L	< 33 U/L	Normal
Thyroid-stimulating hormone	0.77 mU/L	0.35–4.94 mU/L	Normal
Anti-thyroid peroxidase antibodies	8 kU/L	< 34 kU/L	Negative
Anti-thyroglobulin antibodies	27 kU/L	< 115 kU/L	Negative
Immunoglobulin E	3 kU/L	< 100 kU/L	Normal

Return to article view

Declarations

Author contributions

CPR: Conceptualization, Investigation, Writing—original draft. ACG: Conceptualization, Investigation, Writing—original draft. FB: Investigation, Validation, Writing—review & editing. PC: Investigation, Validation. AVM: Validation, Writing—review & editing. SMF: Validation, Writing—review & editing. All authors read and approved the submitted version.

Conflicts of interest

S. M. Ferrucci is a principal investigator in clinical trials to Amgen, Sanofi, Novartis, Lilly, Leo Pharma, AbbVie and she is an advisory board or speaker to Novartis, Menarini, Sanofi, AbbVie and Leo Pharma. A. V. Marzano is on consultancy/advisory boards and received disease-relevant honoraria from AbbVie, Boehringer Ingelheim, Novartis, Pfizer, Sanofi, and UCB. F. Barei has received honoraria from Leo Pharma and Almirall. P. Calzari has received honoraria from Almirall. The other authors declare that there is no conflict of interest.

Ethical approval

The study complies with the Declaration of Helsinki. Ethical approval is not required for a case report study according to the local ethics committee.

Consent to participate

Informed consent to participate in the study was obtained from the participant.

Consent to publication

Informed consent to publication was obtained from the participant.

Availability of data and materials

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Funding

This work was supported by Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico and the Italian Ministry of Health, grant number: [RC 2024]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright

Publisher’s note

Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.

References

Gusdorf L, Lipsker D. Schnitzler Syndrome: a Review. Curr Rheumatol Rep. 2017;19:46. [DOI] [PubMed]

Simon A, Asli B, Braun-Falco M, De Koning H, Fermand JP, Grattan C, et al. Schnitzler’s syndrome: diagnosis, treatment, and follow-up. Allergy. 2013;68:562–8. [DOI] [PubMed]

Gellrich FF, Günther C. Schnitzler syndrome. Dermatologie (Heidelb). 2025;76:6–11. [DOI] [PubMed]

De Aramburu Mera T, Reguero Capilla M, Ochando Diez-Canseco M, Prados Castaño M. Recall Injection-Site Reactions After Treatment With Anakinra. J Investig Allergol Clin Immunol. 2021;31:275–6. [DOI] [PubMed]

Cimbollek S, Ávila-Castellano MR, Labella M, Baynova K, Aramburu T, Quiralte J. Recall Urticaria: Aspirin Also Induces It. J Investig Allergol Clin Immunol. 2018;8:131–2. [DOI] [PubMed]